Our team combines best in class research and years of experience in biotech spin-out management

Mahmood Nazari, Ph.D.

CEO

Dr. Nazari, PhD in AI and Nuclear Medicine, is CEO and Co-Founder of PharmAI. With over 8 years in the pharmaceutical industry, he leads the company’s mission to transform drug discovery through artificial intelligence.

Dr. Andreas Kluge

President

Dr. Kluge is founder and director of ABX-CRO with over 20 years’ experience in nuclear medicine, molecular imaging, and radiopharmaceutical development. He advises PharmAI on clinical translation and strategy.

Christoph Leberecht, Ph.D.

CTO

Dr. Leberecht is an experienced bioinformatician with a background in systems and structural biology. As CTO, he combines his scientific expertise with a passion for software architecture, ensuring PharmAI’s platforms are efficient, reliable, and scalable.

Andreas Fintelmann, Lawyer

CFO

Andreas Fintelmann is a lawyer and seasoned executive with extensive experience in management, finance, and sales. As CFO, he brings strategic and financial leadership to PharmAI.

Michael Schröder, Prof.

CSO

Michael Schröder, Ph.D., Prof., his work spans AI/ML, network biology, and computational drug repositioning; he advises PharmAI on algorithmic strategy and discovery.

Moritz Kallerhoff, MBA

CBO

Moritz Kallerhoff brings extensive business expertise, holding two MBAs and a strong background in strategy and partnerships. He is passionate about identifying new opportunities while fostering trustful, long-term collaborations.

Shanya Singhal

Karin Schubart, Ph.D.

Chief Strategy Officer (CSO)

Dr. Schubart, PhD in Genetics, brings over a decade of experience in translational research and clinical project leadership. At PharmAI, she drives strategic science and partnerships.

Carsten

Dr. Carsten S. Kramer

Advisor

Dr. Kramer is a medicinal chemist and physician with extensive experience in radiopharmaceuticals, molecular imaging, and theranostics. He advises PharmAI on translational strategies bridging chemistry and clinical application.

sebastian

Dr. Sebastian Bittrich

Bioinformatics Expert

Dr. Bittrich is a computational biologist with expertise in structural bioinformatics and molecular modeling. At PharmAI, he contributes to advancing structural prediction and analysis workflows.

Ajay Mohan Mohan

Ajay Mohan Mohan, Ph.D.

Project Manager

Dr. Mohan holds a PhD in molecular imaging and oncology with broad expertise in theranostics and tumor microenvironment research. At PharmAI, he leads the design and execution of preclinical studies.

Florian Kaiser

Florian Kaiser, Ph.D.

Senior Scientist

Background in molecular biology with a keen interest in computer science and passion in computational biology. Dr. Kasier holds a Ph.D. in computer science and has many years of research experience in structural bioinformatics.

Joachim Haupt

Joachim Haupt, Ph.D.

Solution Expert

Dr. Haupt holds a Ph.D. in computer science with a strong background in structural bioinformatics and computational biology. With a decade of business experience and a long scientific track record, he combines entrepreneurship with science as the inventor of PharmAI’s DiscoveryEngine.

Shanya Singhal

Rama Alwattar, M.Sc.

Artificial Intelligence Engineer

Rama holds an M.Sc. in Artificial Intelligence from Germany and brings many years of industrial experience. She contributes to the development of PharmAI’s DiscoveryEngine, advancing its AI capabilities.

Shanya Singhal

Shanya Singhal, M.Sc.

Bioinformatics Engineer

Shanya is passionate about software development and AI - with a strong focus on smart and efficient solutions that make a real impact.